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Abstract 
Background: Femoral neck fractures are associated with high rates of revision 
surgery after management with internal ﬁxation. Using data from the Fixation 
using Alternative Implants for the Treatment of Hip fractures (FAITH) trial 
evaluating methods of internal ﬁxation in patients with femoral neck fractures, we 
investigated associations between baseline and surgical factors and the need for 
revision surgery to promote healing, relieve pain, treat infection or improve 
function over 24 months postsurgery. Additionally, we investigated factors 
associated with (1) hardware removal and (2) implant exchange from cancellous 
screws (CS) or sliding hip screw (SHS) to total hip arthroplasty, hemiarthroplasty, 
or another internal ﬁxation device. 
Methods: We identiﬁed 15 potential factors a priori that may be associated with 
revision surgery, 7 with hardware removal, and 14 with implant exchange. We 
used multivariable Cox proportional hazards analyses in our investigation. 
Results: Factors associated with increased risk of revision surgery included: female 
sex, [hazard ratio (HR) 1.79, 95% conﬁdence interval (CI) 1.25–2.50; P = 0.001], 
higher body mass index (for every 5-point increase) (HR 1.19, 95% CI 1.02–1.39; 
P = 0.027), displaced  fracture (HR 2.16, 95% CI 1.44–3.23; P , 0.001), 
unacceptable quality of implant placement (HR 2.70, 95% CI 1.59–4.55; P , 
0.001), and smokers treated with cancellous screws versus smokers treated with a 
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sliding hip screw (HR 2.94, 95% CI 1.35–6.25; P = 0.006). Additionally, for every 
10-year decrease in age, participants experienced an average increased risk of 39% 
for hardware removal. 
Conclusions: Results of this study may inform future research by identifying high-
risk patients who may be better treated with arthroplasty and may beneﬁt from 
adjuncts to care (HR 1.39, 95% CI 1.05–1.85; P = 0.020). 
 
Introduction 
Hip fractures in elderly adults are common, affecting approximately 1.6 million 
individuals worldwide each year and resulting in a signiﬁcant amount of morbidity 
and mortality.1,2 Fractures of the femoral neck generally necessitate surgical 
management with either internal ﬁxation or arthroplasty and there exists 
controversy surrounding which of these 2 treatment options is optimal in elderly 
patients.3 Typically, most displaced fractures of the femoral neck are treated with 
arthroplasty, but there exists evidence to suggest that internal ﬁxation is better 
suited for treating undisplaced fractures.4 In addition, internal ﬁxation does offer 
some advantages over arthroplasty, including less surgical trauma, allowing the 
patient to retain their own femoral head, and a marginal reduction in mortality and 
morbidity in very frail patients.5 Regardless of treatment option, fractures of the 
femoral neck are associated with high rates of complications, including nonunion, 
delayed union, shortening, infection, and avascular necrosis.3 Our recently 
completed Fixation using Alternative Implants for the Treatment of Hip fractures 
(FAITH) trial found a high revision surgery rate of 20.8%, which was actually 
lower than a previously conducted meta-analysis.6 Revision surgery prolongs 
patients’ recovery time, is associated with higher rates of complications, and 
reduces patients’ health-related quality of life. Identifying factors that are 
associated with revision surgery, and precisely which type of revision surgery, can 
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aid surgeons in making treatment decisions and optimizing the care of hip fracture 
patients. 
The recently completed FAITH randomized controlled trial evaluated the  
effectiveness  of  internal  ﬁxation  with  a sliding hip screw (SHS) versus 
cancellous screws (CS) in patients with a femoral neck fracture.7 The primary 
outcome of this trial was the rate of revision surgery to promote fracture healing, 
relieve pain, treat infection, or improve function within 24 months of fracture.7 
Our primary aim was to identify factors associated with an increased risk of 
revision surgery, as deﬁned above, for patients enrolled in the FAITH trial. Our 
secondary aims were to determine factors associated with an increased risk of 
surgery for hardware removal, deﬁned as the removal of CS or SHS, and surgery 
for implant exchange, deﬁned as the conversion of CS or SHS to total hip 
arthroplasty (THA), hemiarthroplasty (HA), or another internal ﬁxation device. 
 
Materials and Methods 
 
FAITH Study Overview 
The FAITH trial (Clinical Trials Identiﬁcation Number: NCT00761813) enrolled 
1079 patients with a low-energy femoral neck fracture requiring fracture ﬁxation 
from 81 clinical sites in the United States, Canada, Australia, the Netherlands, 
Norway, Germany, the United Kingdom, and India. Patients were assessed 
clinically at 1 and 10 weeks and 6, 9, 12, 18, and 24-months postsurgery. The 
primary outcome of the FAITH trial was revision surgery to promote healing, 
relieve pain, treat infection, or improve function over 24-months postsurgery.7,8 
All revision surgeries were reviewed by a Central Adjudication Committee. The 
trial protocol and results have been previously published.7,8 The trial was 
approved by the Hamilton Integrated Research Ethics Board (#06-402) and by all 
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participating clinical sites’ Research Ethics Boards/Institutional Review Boards. 
 
Selection of Factors 
Based  on biologic rationale  and  previous literature,9  a priori we identiﬁed 22 
potential factors that may be associated with revision surgery, from the baseline 
data, fracture characteristics, and surgical data collected as part of the FAITH trial 
(Table 1).7 When selecting factors for each analysis, we ensured that there were at 
least 10 events for each factor to avoid having an overﬁtted or unstable model.10 
Of note, we had intended to include quality of reduction within the models; 
however, less than 10 patients had unacceptable quality of reduction. Therefore, 
this factor was not included in the models. The number of factors included was 
based on the primary outcome of the FAITH trial, revision surgery. As 224 
participants had a revision surgery to promote healing, relieve pain, treat infection 
or improve function over 24-months post-surgery, all 22 preidentiﬁed factors 
(including levels) could be used in our analysis. We included 15 factors with 22 
levels (Table 1) in our analysis. Because logistic and Cox models require at least 
10 events per covariate to produce stable estimates,10 the minimum number 
participants required to support the analysis of 22 factors would be 220 
participants. As 74 participants underwent hardware removal surgery, we selected 
7 factors that might be associated with hardware removal in our model (Table 2). 
Finally, 150 participants  had implant exchange surgery. Therefore, we selected 14 
factors to be included in this model (Table 3). For every factor in each of our 3 
models, we proposed a priori a hypothesized effect and rationale for revision 
surgery, hardware removal, and implant exchange, respectively. 
 
Data Analysis 
We used multivariable Cox proportional hazards regression stratiﬁed by center 
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analyses to investigate the association between our selected factors and increased 
risk of revision surgery, hardware removal, and implant exchange. An interaction 
term between the randomized treatment and smoking status was added to all 
models because this interaction was found to be signiﬁcant in the FAITH primary 
paper.7 All FAITH patients with complete data for all selected factors were 
included in the analysis. Results were reported as adjusted hazard ratios (HR), 95% 
conﬁdence intervals (CIs), and associated P-values. All tests were 2-tailed with 
alpha = 0.05. We tested the assumption of proportional hazards for all independent 
variables. We performed all analyses using SAS software (version 9.4: SAS 
Institute, Cary, NC). 
 
Results 
 
Participant Characteristics 
Eight hundred ﬁfteen patients enrolled in the FAITH trial had complete prognostic 
and follow-up data for the 15 selected factors and were included in the revision 
surgery model (mean age: 73.4 years; 64% female). Complete data were available 
for 894 (mean age: 73.4 years; 64% female) and 823 (mean age: 73.6 years; 64% 
female) patients to perform the analyses investigating factors associated with 
hardware removal and implant exchange, respectively. Of the patients included in 
this analysis, 191 patients had revision surgeries to promote fracture healing, 
relieve pain, treat infection, or improve function. Within this subset, there were 70 
hardware removal surgeries and 143 implant exchange surgeries (92 conversions to 
THA, 44 conversions to HA, and 9 IF exchanges). 
 
Factors Associated With Revision Surgery 
Female sex (HR 1.79, 95% CI 1.25–2.50; P = 0.001), displaced fracture (HR 2.16, 
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95% CI 1.44–3.23; P , 0.001), and a fracture conﬁguration corresponding to a 
Pauwels type III as compared to type II (HR 2.13, 95% CI 1.28–3.57; P = 0.004) 
were associated with a higher risk of revision surgery (Table 1). Unacceptable 
quality of implant placement, which was adjudicated by the Central Adjudication 
Committee and was deﬁned in the FAITH trial as evidence of prominent screws (at 
the lateral femoral cortex), screw penetration, and lag screw being too high on 
immediate post-operative radiographs, was also found to be associated with a 
higher risk of revision surgery (HR 2.70, 95% CI 1.59–4.55; P , 0.001). Lastly, we 
found that for every 5-point increase in body mass index (BMI), participants 
experienced an average increased risk of 19% for revision surgery (HR 1.19, 95% 
CI 1.02–1.39; P = 0.027) during the 24-month follow-up period. Additionally, we 
found that being treated with CS (compared to SHS) increased the risk of revision 
surgery in patients who were smokers (HR 2.94, 95% CI 1.35–6.25; P = 0.006). 
No other factors were signiﬁcantly associated with revision surgery (P . 0.05). 
 
Factors Associated With Hardware Removal 
Having a displaced fracture (HR 2.91, 95% CI 1.63–5.18; P , 0.001) and 
unacceptable quality of implant placement (HR 2.56, 95% CI 1.11–5.88; P = 
0.027) were associated with an increased risk of hardware removal  (Table 2). We 
found that for every 10-year decrease in age, participants experienced an average 
increased risk of 39% for hardware removal (HR 1.39, 95% CI 1.05–1.85; P = 
0.020) during the 24-month follow-up period. Additionally, we found that being 
treated with CS compared to a SHS was associated with an increased risk of 
hardware removal; however, the treatment effect was signiﬁcantly higher in non-
smokers/prior smokers (HR 0.53, 95% CI 0.29–0.96; P = 0.040) compared to 
current smokers (HR 0.09, 95% CI 0.02–0.37; P = 0.001). BMI and prefracture 
functional status were not associated with hardware removal (P< 0.05). 
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Factors Associated With Implant Exchange 
Factors associated with an increased risk of implant exchange included: female sex 
(HR 2.00, 95% CI 1.32–3.03; P = 0.001), displaced fracture (HR 2.31, 95% CI 
1.45–3.69; P 0.001), and unacceptable quality of implant placement (HR 
2.38, 95% CI 1.32–4.35; P , 0.001) (Table 3). No other factors were signiﬁcantly 
associated with implant exchange (P< 0.05). 
 
Discussion 
Using data from the FAITH trial, we investigated factors associated with revision 
surgery, hardware removal, and implant exchange in patients over the age of 50 
with a low-energy femoral neck fracture.7 To date, there have been a limited 
number of studies that have enrolled large numbers of femoral neck fracture 
patients treated with internal ﬁxation across multiple centers and countries. 
Assessing nearly 1000 participants provided us with greater precision in our 
secondary analyses for determining the factors associated with overall revision 
surgery, hardware removal, and implant exchange surgery. 
In the FAITH primary paper, the interaction between randomized treatment and 
smoking status was found to be statistically signiﬁcant. When this interaction term 
was added to the overall revision surgery model and the hardware removal model, 
a SHS was found to be beneﬁcial in smokers (compared to CS). The existing 
literature concerning the risk of revision surgery in smokers following internal 
ﬁxation of a femoral neck fracture is currently lacking. At this time, only one other 
published study has evaluated factors associated with revision surgery for femoral 
neck fractures, but this study did not assess whether smoking was a factor.9 
However, there is fracture healing literature that suggests that smoking can have a 
negative effect on bone healing.11–14  One systematic review containing 9 tibia 
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studies and 8 other orthopaedic studies found that, overall, smoking had a negative 
effect on bone healing, in terms of delayed union, non-union, and other 
complications.11 Another systematic review found similar ﬁndings that smoking 
signiﬁcantly increased the risk of nonunion of fractures overall [odds ratio (OR) 
2.32; 95% CI 1.76–3.06; P , 0.001], tibial fractures (OR 2.16; 95% CI 1.55–3.01; P 
< 0.001), and open fractures (OR 1.95; 95% CI 1.3–2.9; P , 0.001).12 
Additionally, a recently published prospective, multicentre, cohort study 
evaluating the treatment of acute tibial plateau fractures with open reduction and 
internal ﬁxation found that current smoking was an independent risk factor for the 
development of surgical site infection (OR 5.68; 95% CI 1.56–20.66; P = 
0.009).13 Smoking is also known to have a negative impact on bone density that 
impacts post-surgical fracture mechanical stability.15 Our ﬁnding that smokers 
receiving a SHS will have better outcomes needs to be conﬁrmed through future 
research conducted on this topic. 
Patients with a type III Pauwels fracture compared to type II were found to be at a 
signiﬁcantly higher risk of revision surgery in the current study. However, those 
with    a type III Pauwels fracture were not found to be at a higher risk of revision 
surgery compared to patients with a type I Pauwels fracture. This may have been 
due to a smaller proportion of patients with fractures classiﬁed as type I (n = 
93) or type III (n = 107) compared to type II (n = 615). Although some evidence 
suggests that Pauwels classiﬁcation may not be highly reliable, it is still widely 
used to classify femoral neck fractures.16 
The Gregersen et al9 trial found that underweight elderly  individuals  (BMI  ,19)  
had  a  lower  risk  of  revision surgery compared to elderly individuals with a BMI 
$ 19 (HR 0.33, 95% CI 0.11–0.95; P = 0.040). This ﬁnding was similar to ours and 
may result from the increased amount of stress on the implant. Additionally, the 
Gregersen et al9 trial found that a higher risk of revision surgery was associated 
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with living at home independently compared to living in a nursing home (HR 2.67; 
95% CI 1.35–5.31; P = 0.005) and with poor quality  of fracture reduction in 
displaced fractures (HR 1.95; 95% CI: 1.02–3.72; P = 0.040). Gregersen et al 
deﬁned poor reduction as fracture displacement greater than 5 mm, an 
anteroposterior Garden angle outside the interval of 160–175 degrees, or a 
posterior or anterior angulation greater than 20 degrees.9,17 This ﬁnding was 
consistent with an earlier study which found that poor reduction led to a higher risk 
of treatment failure following internal ﬁxation of displaced fractures of the femoral 
neck.18 Due to a low number of participants with an unacceptable reduction, we 
did not include this factor in our models. Review of the quality of fracture 
reduction by a Central Adjudication Committee in the FAITH trial found that only 
5 participants had unacceptable reduction. Radiographs of the hip fracture were 
examined by the Central Adjudication Committee for approximation of the 
displaced fracture fragments and overall fracture alignment. The Adjudication 
Committee assessed the quality of reduction. Although there are radiologic 
predictors of failure, the absolute cutoffs for acceptable and unacceptable 
reductions are not known. Therefore, the Central Adjudication Committee erred on 
the side of acceptable, except in cases where there was gross malreduction, which 
rarely occurred. 
To ensure that all conversion surgeries were captured, our implant exchange model 
included conversion to THA, HA, or another internal ﬁxation device.19 
Arthroplasty involves partial or full replacement of a joint, whereas internal 
ﬁxation involves joint preservation. Therefore, the two procedures are very 
different clinically. For this reason, we repeated the implant exchange analysis 
removing the 9 patients who underwent implant exchange to another internal 
ﬁxation device. Typically, implant exchanges mostly involve THA and HA 
procedures, whereas implant exchanges to another internal ﬁxation device are less 
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common. We found similar results to our original analysis where female sex (P = 
0.001), displaced fracture (P = 0.0003), and unacceptable quality of implant 
placement (P = 0.006) were associated with an increased risk of CS or SHS 
conversion to THA or HA. Unlike in the original analysis, using an ambulatory aid 
prefracture (P = 0.04) was also found to be associated with an increased risk of CS 
or SHS conversion to THA or HA. 
Our study has numerous notable strengths. A total of 1079 patients from 81 
clinical sites in the United States, Canada, Australia, the Netherlands, Norway, 
Germany, the United Kingdom, and India were included in the FAITH trial. The 
large sample size and diversity of the participants included in the trial increases the 
external validity and generalizability of our research ﬁndings from this analysis. 
The 7 postsurgery follow-up visits across a 24-month period allowed for frequent 
and long-term assessment of participant outcomes and all revision surgery events 
were centrally adjudicated. Additionally, the use of a multivariable Cox 
proportional hazards regression for our analysis was advantageous, as this type of 
model helps control for numerous potentially confounding variables when the 
sample size is large enough.20 Although this study had several strengths, 
important limitations do exist. Although 1079 patients were included in the 
primary analysis of the FAITH trial, it was not possible to include them all in this 
analysis, due to missing data. Also, it may be possible that not all factors 
associated with revision surgery were collected as part of the FAITH trial. Bone 
density determination is one important factor in this regard. Only variables 
collected as part of the FAITH trial could be used in our analysis. 
Identifying factors associated with revision surgery will help to optimize the care 
of hip fracture patients. Understanding which patients are at risk for revision 
surgery, and speciﬁcally which type of revision surgery, can let surgeons 
communicate these risks to patients when explaining treatment options and 
• 
 
prognosis. Additionally, the variables identiﬁed in our analysis may allow for 
surgeons to consider alternate care options, such as joint replacement, for patients 
who are at higher risk of revision surgery. Finally, the results of this study may 
also inform future research by identifying high-risk patients who may beneﬁt from 
novel interventions and adjuncts to care. 
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